Skip to main content

Table 5 Comparison of serum LAPTM4B levels in patients with LAC between different chemotherapy efficacy groups (median(IQR))

From: LAPTM4B is a novel diagnostic and prognostic marker for lung adenocarcinoma and associated with mutant EGFR

Efficacy

Number

LAPTM4B(ng/mL)

P value

PR + CR

49

6.917 (8.458)

0.039

PD + SD

130

9.819 (12.110)